✦ LIBER ✦

Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer

✍ Scribed by Tzong-Shin Tzai; Yuh-Shyan Tsai; Ai-Li Shiau; Chao-Liang Wu; Gia-Shing Shieh; Hsin-Tzu Tsai

Book ID: 116945442
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 295 KB
Volume: 67
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2005.08.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined morphologic and fluorescence in

Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology

✍ Daniely, Michal ;Rona, Roni ;Kaplan, Tal ;Olsfanger, Shirley ;Elboim, Lea ;Freib 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

BACKGROUND. Bladder cancer is among the 5 most common malignancies worldwide. Patients with bladder cancer are closely followed with periodic cystoscopies and urine cytology analyses due to the significant risk of tumor recurrence. The UroVysion fluorescence in situ hybridization (FISH) test demonst

Aberrant Methylation of RAR 2 and APC Ge

Aberrant Methylation of RAR 2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer

✍ Eissa, S.; Swellam, M.; El-Khouly, I. M.; Kassim, S. K.; Shehata, H.; Mansour, A 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 660 KB

1265 NUCLEAR MATRIX PROTEIN 22 (NMP22) A

1265 NUCLEAR MATRIX PROTEIN 22 (NMP22) AS URINE-BASED TUMOR MARKER FOR DETECTION OF PRIMARY AND RECURRENT BLADDER CANCER: COMPARISON OF THE POINT-OF-CARE VERSION (BLADDERCHEK®) AND THE ELISA

✍ Hatzichristodoulou, Georgios; Kuebler, Hubert; Schwaibold, Hartwig; Wagenpfeil, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Combined morphologic and fluorescence in

Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology: Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I, BioView Ltd., Rehovot, Israel.

✍ H. Barton Grossman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 37 KB